SCHEMBL2177158

SCHEMBL2177158

CNc1nccc(-c2cc(NC(=O)CN3CCN(CCn4cccc4)CC3)c3cc(OC)ccc3c2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.41
ALDH1A1 P00352 6/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
KDM4E B2RXH2 2/20 0.40
CYP3A4 P08684 1/20 0.40
MAPK1 P28482 1/20 0.40
JAK2 O60674 2/20 0.40
HDAC1 Q13547 2/20 0.40
HDAC6 Q9UBN7 2/20 0.40
LMNA P02545 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 2/20 0.39
KCNA5 P22460 2/20 0.39
HPGD P15428 1/20 0.38
HIF1A Q16665 1/20 0.38
MAPT P10636 2/20 0.38
HTT P42858 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2184977 0.92 KDR (0.42) KMT2AALDH1A1KDM4EJAK2HDAC1
SCHEMBL2178862 0.92 JAK2 (0.40) KMT2AALDH1A1KDM4EJAK2HDAC1
SCHEMBL2181492 0.91 KMT2A (0.46) KMT2AALDH1A1KDM4EMAPK1HPGD
SCHEMBL2178573 0.91 TP53 (0.45) KMT2AALDH1A1KDM4EJAK2HDAC1
SCHEMBL2180895 0.90 KCNA5 (0.43) KMT2AALDH1A1JAK2HDAC1HDAC6
SCHEMBL2180042 0.89 JAK2 (0.42) KMT2AJAK2HDAC1HDAC6MEN1
SCHEMBL2181105 0.89 MAPK13 (0.46) KMT2AALDH1A1KDM4EMAPK1HPGD
SCHEMBL2176488 0.88 KMT2A (0.40) KMT2AALDH1A1JAK2HDAC1HDAC6
SCHEMBL2179087 0.88 KMT2A (0.42) KMT2AALDH1A1KDM4EJAK2HDAC1
SCHEMBL2178170 0.87 KMT2A (0.43) KMT2AALDH1A1KDM4ELMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US claimed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed
WO-2011082268-A2 SUBSTITUTED NAPHTHALENYL-PYRIMIDINE COMPOUNDS ARQULE INC. (US) 2011-07-07 WO disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds DPYD, TP53, TYMP KMT2A 2050/4885ALDH1A1 619/4885CYP1A2 2092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.